Table 3.
Age-Adjusted Incidence Rates (AAIR)* of selected first primary malignant and benign central nervous system tumors by histology and sex, California, 2001–2005
| Behavior | Histology | Sex | Total | NH White | NH Black | Hispanic | API | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AAIR | 95% CI | AAIR | 95% CI | AAIR | 95% CI | AAIR | 95% CI | AAIR | 95% CI | |||
| Malignant | Astrocytoma, anaplastic | Total | 0.4 | 0.3, 0.4 | 0.5 | 0.4, 0.5 | 0.1 | 0.1, 0.2 | 0.3 | 0.3, 0.4 | 0.2 | 0.2, 0.3 |
| Male | 0.4 | 0.4, 0.5 | 0.6 | 0.5, 0.6 | 0.1 | 0.0, 0.2 | 0.4 | 0.3, 0.5 | 0.3 | 0.2, 0.4 | ||
| Female | 0.3 | 0.3, 0.4 | 0.4 | 0.3, 0.5 | 0.2 | 0.1, 0.3 | 0.3 | 0.2, 0.4 | 0.2 | 0.1, 0.3 | ||
| Astrocytoma, NOS | Total | 0.3 | 0.3, 0.4 | 0.4 | 0.4, 0.5 | 0.2 | 0.2, 0.4 | 0.3 | 0.3, 0.4 | 0.2 | 0.1, 0.2 | |
| Male | 0.4 | 0.3, 0.4 | 0.5 | 0.4, 0.5 | 0.4 | 0.2, 0.6 | 0.4 | 0.3, 0.5 | 0.2 | 0.1, 0.3 | ||
| Female | 0.3 | 0.3, 0.3 | 0.3 | 0.3, 0.4 | 0.1 | 0.1, 0.3 | 0.3 | 0.2, 0.4 | 0.2 | 0.1, 0.3 | ||
| Glioblastoma | Total | 2.6 | 2.5, 2.7 | 3.1 | 3.0, 3.2 | 1.5 | 1.3, 1.8 | 2.3 | 2.1, 2.5 | 1.2 | 1.1, 1.4 | |
| Male | 3.3 | 3.1, 3.4 | 3.9 | 3.7, 4.1 | 2.0 | 1.6, 2.5 | 2.8 | 2.5, 3.1 | 1.6 | 1.3, 1.9 | ||
| Female | 2.0 | 1.9, 2.1 | 2.4 | 2.3, 2.5 | 1.1 | 0.9, 1.5 | 1.9 | 1.7, 2.2 | 0.9 | 0.7, 1.1 | ||
| Oligodendroglioma | Total | 0.3 | 0.2, 0.3 | 0.3 | 0.3, 0.4 | 0.1 | 0.0, 0.2 | 0.2 | 0.2, 0.2 | 0.2 | 0.1, 0.2 | |
| Male | 0.3 | 0.3, 0.3 | 0.4 | 0.3, 0.5 | 0.1 | 0.0, 0.3 | 0.2 | 0.1, 0.3 | 0.2 | 0.1, 0.3 | ||
| Female | 0.2 | 0.2, 0.2 | 0.3 | 0.2, 0.3 | 0.1 | 0.0, 0.2 | 0.2 | 0.1, 0.3 | 0.1 | 0.1, 0.2 | ||
| Anaplastic oligodendroglioma | Total | 0.1 | 0.1, 0.1 | 0.2 | 0.1, 0.2 | 0.0 | 0.0, 0.1 | 0.1 | 0.1, 0.1 | 0.1 | 0.1, 0.1 | |
| Male | 0.1 | 0.1, 0.1 | 0.1 | 0.1, 0.2 | 0.1 | 0.0, 0.2 | 0.1 | 0.1, 0.2 | 0.1 | 0.1, 0.2 | ||
| Female | 0.1 | 0.1, 0.1 | 0.2 | 0.1, 0.2 | 0.0 | 0.0, 0.1 | 0.1 | 0.0, 0.1 | 0.1 | 0.0, 0.1 | ||
| Ependymomas, anaplastic | Total | 0.2 | 0.2, 0.3 | 0.3 | 0.2, 0.3 | 0.2 | 0.1, 0.3 | 0.2 | 0.2, 0.3 | 0.2 | 0.1, 0.2 | |
| Male | 0.2 | 0.2, 0.3 | 0.3 | 0.2, 0.3 | 0.2 | 0.1, 0.4 | 0.2 | 0.2, 0.3 | 0.1 | 0.1, 0.2 | ||
| Female | 0.2 | 0.2, 0.3 | 0.3 | 0.2, 0.3 | 0.2 | 0.1, 0.3 | 0.2 | 0.2, 0.3 | 0.2 | 0.1, 0.3 | ||
| Mixed glioma | Total | 0.2 | 0.2, 0.2 | 0.2 | 0.2, 0.3 | 0.1 | 0.0, 0.2 | 0.1 | 0.1, 0.2 | 0.2 | 0.1, 0.2 | |
| Male | 0.2 | 0.2, 0.2 | 0.3 | 0.2, 0.3 | 0.1 | 0.0, 0.2 | 0.1 | 0.1, 0.2 | 0.2 | 0.1, 0.3 | ||
| Female | 0.2 | 0.1, 0.2 | 0.2 | 0.1, 0.2 | 0.1 | 0.0, 0.3 | 0.1 | 0.1, 0.2 | 0.2 | 0.1, 0.2 | ||
| Glioma malignant, NOS | Total | 0.3 | 0.3, 0.3 | 0.3 | 0.3, 0.4 | 0.3 | 0.2, 0.4 | 0.3 | 0.2, 0.3 | 0.2 | 0.2, 0.3 | |
| Male | 0.3 | 0.3, 0.4 | 0.4 | 0.3, 0.4 | 0.3 | 0.1, 0.5 | 0.3 | 0.2, 0.4 | 0.3 | 0.2, 0.4 | ||
| Female | 0.3 | 0.2, 0.3 | 0.3 | 0.2, 0.4 | 0.3 | 0.2, 0.5 | 0.3 | 0.2, 0.4 | 0.2 | 0.1, 0.3 | ||
| PNET/Meduloblastoma | Total | 0.2 | 0.2, 0.2 | 0.2 | 0.2, 0.3 | 0.1 | 0.1, 0.2 | 0.2 | 0.2, 0.3 | 0.2 | 0.1, 0.2 | |
| Male | 0.3 | 0.2, 0.3 | 0.3 | 0.2, 0.4 | 0.1 | 0.0, 0.2 | 0.3 | 0.2, 0.4 | 0.1 | 0.1, 0.2 | ||
| Female | 0.2 | 0.1, 0.2 | 0.2 | 0.1, 0.2 | 0.1 | 0.0, 0.2 | 0.2 | 0.1, 0.2 | 0.2 | 0.1, 0.3 | ||
| Lymphomas | Total | 0.4 | 0.4, 0.5 | 0.4 | 0.4, 0.5 | 0.4 | 0.3, 0.5 | 0.4 | 0.3, 0.5 | 0.5 | 0.4, 0.6 | |
| Male | 0.5 | 0.5, 0.6 | 0.5 | 0.4, 0.6 | 0.4 | 0.3, 0.6 | 0.5 | 0.4, 0.6 | 0.6 | 0.4, 0.7 | ||
| Female | 0.3 | 0.3, 0.4 | 0.3 | 0.3, 0.4 | 0.3 | 0.2, 0.5 | 0.3 | 0.2, 0.4 | 0.4 | 0.3, 0.5 | ||
| Benign | Pilocytic astrocytoma | Total | 0.3 | 0.2, 0.3 | 0.4 | 0.3, 0.4 | 0.2 | 0.2, 0.3 | 0.2 | 0.2, 0.2 | 0.1 | 0.1, 0.2 |
| Male | 0.3 | 0.2, 0.3 | 0.4 | 0.3, 0.4 | 0.2 | 0.1, 0.4 | 0.2 | 0.2, 0.3 | 0.1 | 0.1, 0.2 | ||
| Female | 0.3 | 0.2, 0.3 | 0.4 | 0.3, 0.5 | 0.2 | 0.1, 0.4 | 0.2 | 0.2, 0.3 | 0.2 | 0.1, 0.3 | ||
| Nerve sheath | Total | 1.5 | 1.4, 1.6 | 1.8 | 1.7, 1.8 | 0.7 | 0.5, 0.9 | 1.0 | 0.9, 1.1 | 1.5 | 1.3, 1.7 | |
| Male | 1.6 | 1.5, 1.7 | 1.9 | 1.7, 2.0 | 0.8 | 0.5, 1.0 | 0.9 | 0.8, 1.1 | 1.6 | 1.4, 1.9 | ||
| Female | 1.4 | 1.4, 1.5 | 1.7 | 1.5, 1.8 | 0.6 | 0.4, 0.9 | 1.0 | 0.9, 1.2 | 1.4 | 1.2, 1.6 | ||
| Meningioma | Total | 4.5 | 4.4, 4.6 | 4.7 | 4.5, 4.8 | 5.0 | 4.5, 5.5 | 4.0 | 3.7, 4.2 | 4.2 | 3.9, 4.5 | |
| Male | 2.7 | 2.5, 2.8 | 2.9 | 2.7, 3.1 | 3.2 | 2.6, 3.8 | 2.0 | 1.7, 2.2 | 2.3 | 2.0, 2.7 | ||
| Female | 6.1 | 5.9, 6.3 | 6.3 | 6.1, 6.5 | 6.5 | 5.8, 7.2 | 5.7 | 5.3, 6.1 | 5.8 | 5.3, 6.2 | ||
| Pituitary tumors | Total | 2.0 | 1.9, 2.1 | 1.7 | 1.6, 1.8 | 3.2 | 2.9, 3.6 | 2.5 | 2.3, 2.7 | 1.8 | 1.6, 2.0 | |
| Male | 2.1 | 2.0. 2.2 | 1.8 | 1.7, 2.0 | 3.8 | 3.2, 4.5 | 2.5 | 2.3, 2.8 | 1.8 | 1.5, 2.1 | ||
| Female | 2.0 | 1.9, 2.1 | 1.6 | 1.5, 1.7 | 3.0 | 2.5, 3.5 | 2.6 | 2.4, 2.8 | 1.8 | 1.6, 2.1 | ||
* Age-adjusted incidence rates are per 100,000 population. Rates are standardized to the 2000 US population
PNET primitive neuroectodermal tumors